Cargando…
Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051851/ https://www.ncbi.nlm.nih.gov/pubmed/33892926 http://dx.doi.org/10.1016/j.jaci.2021.03.034 |
| _version_ | 1783679812923031552 |
|---|---|
| author | Lemarquis, Andri Campbell, Tessa Aranda-Guillén, Maribel Hennings, Viktoria Brodin, Petter Kämpe, Olle Blennow, Kaj Zetterberg, Henrik Wennerås, Christine Eriksson, Kristina Landegren, Nils Bryceson, Yenan Berg, Stefan Ekwall, Olov |
| author_facet | Lemarquis, Andri Campbell, Tessa Aranda-Guillén, Maribel Hennings, Viktoria Brodin, Petter Kämpe, Olle Blennow, Kaj Zetterberg, Henrik Wennerås, Christine Eriksson, Kristina Landegren, Nils Bryceson, Yenan Berg, Stefan Ekwall, Olov |
| author_sort | Lemarquis, Andri |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8051851 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80518512021-04-19 Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis Lemarquis, Andri Campbell, Tessa Aranda-Guillén, Maribel Hennings, Viktoria Brodin, Petter Kämpe, Olle Blennow, Kaj Zetterberg, Henrik Wennerås, Christine Eriksson, Kristina Landegren, Nils Bryceson, Yenan Berg, Stefan Ekwall, Olov J Allergy Clin Immunol Correspondence American Academy of Allergy, Asthma & Immunology 2021-07 2021-04-16 /pmc/articles/PMC8051851/ /pubmed/33892926 http://dx.doi.org/10.1016/j.jaci.2021.03.034 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Lemarquis, Andri Campbell, Tessa Aranda-Guillén, Maribel Hennings, Viktoria Brodin, Petter Kämpe, Olle Blennow, Kaj Zetterberg, Henrik Wennerås, Christine Eriksson, Kristina Landegren, Nils Bryceson, Yenan Berg, Stefan Ekwall, Olov Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis |
| title | Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis |
| title_full | Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis |
| title_fullStr | Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis |
| title_full_unstemmed | Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis |
| title_short | Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis |
| title_sort | severe covid-19 in an aps1 patient with interferon autoantibodies treated with plasmapheresis |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051851/ https://www.ncbi.nlm.nih.gov/pubmed/33892926 http://dx.doi.org/10.1016/j.jaci.2021.03.034 |
| work_keys_str_mv | AT lemarquisandri severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT campbelltessa severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT arandaguillenmaribel severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT henningsviktoria severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT brodinpetter severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT kampeolle severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT blennowkaj severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT zetterberghenrik severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT wenneraschristine severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT erikssonkristina severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT landegrennils severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT brycesonyenan severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT bergstefan severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis AT ekwallolov severecovid19inanaps1patientwithinterferonautoantibodiestreatedwithplasmapheresis |